- Tue02Feb2016
Royal Marsden Hospital, London
Description: 1-day course describing the recent advances made in targeted treatments for cancer, using malignant melanoma as the primary example. Delegates will learn about the faulty genes, pathways and proteins that drive malignant melanoma and other solid tumours, and the mechanism of action of targeted treatments such as B-Raf inhibitors and MEK inhibitors. The day also includes an overview of immunotherapy approaches for cancer, including T cell-based treatments and checkpoint inhibitors.
Level: Intermediate
Audience: Ideal for research nurses, clinical nurse specialists, administrative staff, clinical trials coordinators
Cost: £160
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View the programme - Mon25Apr2016
Royal Marsden Hospital
Description: This course describes the faulty genes, pathways and proteins that drive small cell and non-small cell lung cancer. It also explains the scientific rationale behind targeted treatments in use and in development for these diseases, such as EGFR inhibitors, ALK inhibitors, angiogenesis inhibitors and immunotherapy.
Level: Intermediate/advanced
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
Cost: £150
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
View the programme - Tue24May2016
Christie Hospital, Manchester
Description: 1 day course providing an overview of the cellular and genetic makeup of breast cancer and explains the science behind targeted treatments in use and in development. Includes an overview of hormone treatments and chemotherapy.
Level: Intermediate
Audience: Ideal for research nurses, clinical nurse specialists, administrative staff, clinical trials coordinators
To book, contact: education.events@christie.nhs.uk or call: 0161 446 3403
View the programme - Tue05Jul2016
Royal Marsden Hospital, London
Description: 1-day course describing the cellular and genetic features of haematological cancers and targeted treatments for these cancers
Level: Advanced
Audience: Ideal for research nurses, pharmacists, pharmaceutical companies, junior doctors or anyone who has been on one of my other coursesCost: £150
To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
Book online or view the programme - Tue06Sep2016Wed07Sep2016
Christie Hospital, Manchester
Description: This 2-day course provides a grounding in cancer biology before moving to descriptions of a wide range of targeted treatments for solid tumours. Also includes mechanisms of drug resistance and an introduction to biomarkers and personalised cancer care.
Level: Intermediate
Audience: Ideal for research nurses, clinical nurse specialists, administrative staff, clinical trials coordinators
To book, contact: education.events@christie.nhs.uk
View the programme - Sun06Nov2016Wed09Nov2016
08.15 - 09.00 Monday & Tuesday morningBT Convention Centre, Liverpool
For those of you attending this year's NCRI conference in Liverpool, I will be running workshops on Monday and Tuesday morning to de-mystify the scientific content of each day's programme.
My workshops are for people who plan to attend the day's lectures whilst fearing that they won’t understand the relevant scientific concepts.
My workshops will explain words, concepts and ideas, such as:
- Biomarkers and how they relate to personalized medicine
- Epigenetics
- Cancer metabolism
- The ideas behind cancer immunotherapy
- Genetic instability and intra-tumoural heterogeneity
- What we mean by ‘genomics trials’
Similar to previous years’ workshops, I will use diagrams and illustrations to provide clear, easy-to-understand explanations of complicated biological concepts.
The workshops are geared towards non-scientists, such as doctors, nurses, trials staff and patients who’d like to get the most out of this year’s conference.
- Mon05Dec2016
Royal Marsden Hospital, London
Description: 1-day course covering a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level. Treatments described include: growth factor receptor inhibitors, kinase inhibitors, monoclonal antibodies, PARP inhibitors, ALK inhibitors, CDK inhibitors, immunotherapies.
Level: Advanced
Audience: Ideal for pharmacists, scientifically-minded nurses, pharmaceutical companies, junior doctors
To book, contact: conferenceteam@rmh.nhs.uk
View the programme